| Windlas Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543329 |
NSE Symbol : WINDLAS |
P/E(TTM) : 26.47 |
|
ISIN Demat : INE0H5O01029 |
Div & Yield% : 0.74 |
EPS(TTM) : 32.19 |
|
Book Value(₹) : 281.35 |
Market Cap(₹Cr) : 1,758.31 |
Face Value(₹) : 5.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 238.50 | 233.10 | 222.40 | 210.09 | 202.71 | 195.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 238.50 | 233.10 | 222.40 | 210.09 | 202.71 | 195.02 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.40 | 4.52 | 3.65 | 5.24 | 4.94 | 3.73 |
| Total Income | 242.90 | 237.62 | 226.04 | 215.33 | 207.65 | 198.75 |
| Total Expenditure | 213.26 | 208.73 | 193.84 | 183.57 | 177.16 | 170.38 |
| PBIDT | 29.64 | 28.90 | 32.20 | 31.76 | 30.49 | 28.37 |
| Interest | 1.48 | 1.28 | 1.02 | 1.06 | 1.33 | 1.46 |
| PBDT | 28.16 | 27.62 | 31.19 | 30.71 | 29.16 | 26.91 |
| Depreciation | 8.00 | 7.70 | 7.60 | 7.45 | 8.34 | 6.94 |
| Tax | 4.81 | 4.46 | 5.88 | 5.55 | 4.61 | 3.92 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.66 | 0.51 | -0.09 | 0.04 | -0.06 | 0.82 |
| Reported Profit After Tax | 16.02 | 14.95 | 17.80 | 17.67 | 16.29 | 15.23 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.02 | 14.95 | 17.80 | 17.67 | 16.29 | 15.23 |
| EPS (Unit Curr.) | 7.60 | 7.09 | 8.48 | 8.43 | 7.77 | 7.29 |
| EPS (Adj) (Unit Curr.) | 7.60 | 7.09 | 8.48 | 8.43 | 7.77 | 7.29 |
| Calculated EPS (Unit Curr.) | 7.59 | 7.09 | 8.44 | 8.43 | 7.77 | 7.29 |
| Calculated EPS (Adj) (Unit Curr.) | 7.59 | 7.09 | 8.44 | 8.43 | 7.77 | 7.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 30.35 | 28.38 | 33.78 | 33.71 | 31.08 | 29.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 30.35 | 28.38 | 33.78 | 33.71 | 31.08 | 29.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.55 | 10.54 | 10.54 | 10.48 | 10.48 | 10.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.43 | 12.40 | 14.48 | 15.12 | 15.04 | 14.55 |
| PBDTM(%) | 11.81 | 11.85 | 14.02 | 14.62 | 14.39 | 13.80 |
| PATM(%) | 6.72 | 6.41 | 8.00 | 8.41 | 8.04 | 7.81 |
